Delivery Order SPE2DR25D1103-SPE2DR26FE223
- Not listed
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injector vials with a ceiling value of $1,114.96. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 19, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,964.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, which carries an ultimate completion date of September 11, 2025, represents a competitively awarded, non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $1,621.07 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors on November 5, 2025, with an ultimate completion date of November 6, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract involves no set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors with a ceiling value of $1,451.90 and a firm fixed price. This is a non-set-aside, competitively awarded contract with an ultimate completion date of November 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,908.36 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This firm fixed-price contract, designated as a non-set-aside award, represents a competitive procurement action and will be completed by December 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, which falls under the company's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors with a ceiling value of $1,411.51. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. Sumatriptan is a migraine treatment...
- The Defense Logistics Agency awarded a delivery order valued at $7,615.55 to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector supplies on August 26, 2025, with completion scheduled for August 27, 2025. This contract utilizes firm fixed-price pricing and was competitively awarded without set-aside restrictions. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,534.04 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors on December 18, 2025, with completion scheduled for December 19, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,137.07 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, awarded on July 23, 2025, with a completion date of July 24, 2025, utilizes firm fixed pricing with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.97 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This competitive award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE223Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a Firm Fixed Price delivery order from the Defense Logistics Agency (DLA) on December 5, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract ceiling value is $9,501.85, with an ultimate completion date of December 8, 2025. This delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA and the Department of Defense healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to support military healthcare programs globally. Sumatriptan, a migraine treatment medication, falls within the neurological therapeutic domain that AmerisourceBergen regularly provides through its federal medical supply portfolio serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 12/4/25 |